Cigna Group $CI Shares Acquired by AustralianSuper Pty Ltd

AustralianSuper Pty Ltd grew its position in Cigna Group (NYSE:CIFree Report) by 816.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 106,699 shares of the health services provider’s stock after acquiring an additional 95,052 shares during the quarter. AustralianSuper Pty Ltd’s holdings in Cigna Group were worth $30,756,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. Brighton Jones LLC grew its holdings in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares in the last quarter. Sivia Capital Partners LLC boosted its position in Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after acquiring an additional 109 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in Cigna Group by 3.9% during the 2nd quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock valued at $11,882,000 after acquiring an additional 1,357 shares in the last quarter. Capital Investment Advisors LLC raised its holdings in Cigna Group by 18.5% in the 2nd quarter. Capital Investment Advisors LLC now owns 1,877 shares of the health services provider’s stock valued at $620,000 after acquiring an additional 293 shares during the last quarter. Finally, Trivium Point Advisory LLC purchased a new position in Cigna Group in the 2nd quarter worth approximately $224,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CI. UBS Group set a $294.00 price target on Cigna Group in a report on Wednesday, November 12th. Mizuho set a $325.00 target price on Cigna Group in a report on Friday, January 9th. Morgan Stanley reiterated an “overweight” rating and set a $355.00 price target on shares of Cigna Group in a report on Friday, October 31st. Jefferies Financial Group reissued a “buy” rating and issued a $310.00 price objective on shares of Cigna Group in a report on Monday, November 3rd. Finally, Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $330.36.

Get Our Latest Stock Analysis on Cigna Group

Insider Buying and Selling at Cigna Group

In other news, CEO David Cordani acquired 4,134 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The shares were purchased at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.70% of the company’s stock.

Cigna Group Trading Down 0.4%

Shares of CI stock opened at $271.18 on Friday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The firm has a market cap of $72.44 billion, a PE ratio of 11.96, a price-to-earnings-growth ratio of 0.96 and a beta of 0.26. The company has a 50-day moving average of $274.66 and a two-hundred day moving average of $284.85. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the prior year, the business posted $7.51 EPS. On average, analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.